Click here to join the
Colloidal Silver Secrets
Community on Facebook
|
Click here to join the Colloidal Silver Secrets Community on Facebook |
|
|
Big Pharma Ignores Colloidal Silver,
Says Taxpayers Must Fund Research Into New Antibiotic Drugs Or Risk Dying of
Superbug Infections!
Did you ever
wonder why the European Union banned the sale of colloidal silver back in
January of 2010, just as new studies began demonstrating how effective it is
against the growing threat of antibiotic-resistant super-pathogens?
Is it any
coincidence that Big Pharma is now threatening to let
millions of people DIE of superbug infections unless taxpayers start footing
the bill for the needed new antibiotic drugs…and that the governments of the European
Union are now the first ones to have caved in to their demands?
Hi,
Steve Barwick here, for www.TheSilverEdge.com...
According
to this news article, Europe is
in the grip of a massive superbug crisis that shows no sign of abating.
At
the same time, Big Pharma has purposely -- and
callously -- cut back on research and development into new antibiotic drugs to
combat the superbug crisis.
This
has left the nations of the European Union in a life-threatening bind.
EU
governments are now being forced to institute programs through which European taxpayers will foot the bill for Big Pharma’s research and development of new antibiotic drugs.
Afterwards,
the drug companies will be allowed to sell the drugs they’ve developed on the
taxpayer dime for massive profits.
So
taxpayers foot the bill both ways.
They
pay for the research and development of the new antibiotic drugs through higher
taxes, and then they pay for the new "wonder drugs" developed at
their expense.
As
Andrew Witty, Chief Executive of the drug company GlaxoSmithKline said about
the new plan to have taxpayers foot the bill for the development of new
antibiotic drugs to fight the superbug crisis:
|
“The Commission's plans were a welcome step forward that could
help bring more antibiotics to market. Unfortunately, the current commercial
model doesn't stimulate the innovation needed in this area. We need a fundamentally different approach and public-private
collaboration, with the sharing of information and funding, provides us
with a significant opportunity to reduce the hurdles in our way." |
Translation:
|
“Make the taxpayers foot the bill for all of our research and development
costs, and we’ll develop some new drugs to help combat the superbug crisis. Otherwise, you can all eat shit and die if you get a superbug
infection because we’re not going to develop any more drugs if we have to pay
for the research and development out of our own profits.” |
Folks,
these big drug companies make hundreds of
billions of dollars a year selling drugs at exorbitant prices that cost
them only pennies to produce.
And
now they want the beleaguered taxpayers to foot the bill for all of their
research and development costs for new antibiotic drugs to fight super-pathogens…
…or
else they’ll just sit back on their haunches and allow millions of people
worldwide to die from superbug infections each year!
Are
you beginning to see why the European
Union banned the sale of colloidal silver back in 2010?
With
no alternative natural means of fighting superbug infections, the taxpayers of
the European Union now have no choice but pay Big Pharma
billions of dollars annually to develop new antibiotic drugs for them!
Some
people say the bankers run the world.
But I’ll tell you what: There’s
little doubt in my mind Big Pharma is right up there
with them.
Coming to
America!
And
don’t think the same thing won’t happen here.
The
very same propaganda campaign used in Europe to force the taxpayers to pay Big Pharma’s research and development costs for new antibiotic
drugs is already being implemented here in the U.S., too. In fact, the propaganda campaign for it has
been underway since last year.
“We're
running out of antibiotic drugs," said Dr. Brad Spellberg
of UCLA Medical Center, an infectious disease expert. He says the pharmaceutical companies have
stopped making enough antibiotics because it's just “not profitable.”
Indeed, according to the Infectious Disease Society of America, as of 2010 only
a mere five of the 13 biggest pharmaceutical companies are still even considering developing new antibiotic
drugs.
And
according to an article in Newsweek magazine,
the drug companies now claim profits are just not high enough to justify the
development of new antibiotic drugs, particularly when compared to the money
that can be made by developing drugs for chronic, long-term diseases such as
cancer, heart disease or even baldness:
“Medications that treat cancer or chronic conditions like
diabetes, heart disease, or even baldness are simply much more lucrative [than
antibiotic drugs].
That’s because a single course of the most expensive antibiotics (linezolid and daptomycin) runs
just seven days and sells for $1,000 to $2,000, while a single course of, say,
any given cancer treatment runs for weeks to months and costs from 10 to 20
times as much.
Chronic-disease medications, which a patient typically takes for
the rest of his or her life, yield even higher returns. It doesn’t matter that
bacterial infections are infinitely more common than cancer or even heart
disease; antibiotics are still less profitable…
… The future will almost certainly be different. Antibiotics will
cost more and do less. They will also be less readily available than we are
accustomed to.”
Ahhh…did they just say ya’ll gonna die
because we’re not making enough money off your stupid infections, but if you’ve
got cancer, heart disease or are going bald we’ve got you covered with
expensive drugs you can take for the rest of your life?
I
think you read that right, my friend!
According
to the book, The Truth About
the Drug Companies: How They Deceive Us
and What to Do About It, by Marcia Angell, “Drug companies often
decided to stop making important drugs in order to free up capacity for drugs
with bigger market potential.”
Translation: It’s not that the antibiotic drugs aren’t
profitable to produce. It’s that other
drugs are much more profitable. And the drug companies would rather produce
the more profitable drugs, even though it means millions of lives will be lost
as a consequence of cutting back on the production of the less profitable drugs.
According
to an article in Time magazine titled
“The Desperate Need for New Antibiotics,” David Payne, head of
GlaxoSmithKline's Antibacterial Discovery Performance Unit says “incentives”
would certainly help his research team, which is one of the few left in major
pharmaceutical firms that continue to develop new classes of antibiotics.
"A lot of people don't appreciate that in big companies it's
a pretty competitive environment for funding for each of the therapeutic areas.
Incentives would offer a way for us to accelerate our program and
increase our probability of success."
Of
course, “incentives” is the new code word for taxpayer funding. Mr. Payne wants the government to provide
taxpayer dollars as an “incentive” to develop more antibiotic drugs. Otherwise, the death rate from the superbugs
is going to soar.
Why
don’t the drug companies simply fund the needed research out of the hundreds of
billions of dollars in profits they make each year from the sale of their other
prescription drugs?
Well,
why should they, when they can simply
stop producing new antibiotic drugs until death rates from the super-pathogens skyrocket
to the point that the governments of the world are forced to start ponying up taxpayer money to fund the research, instead?
Says
a November 2010 article in the New York
Times:
“While the notion of directly subsidizing drug companies may be
politically unpopular in many quarters, proponents say it is necessary to
bridge the gap between the high value that new antibiotics have for society and
the low returns they provide to drug companies.”
Fear-based
propaganda, my friends, pure and simple!
Indeed,
with characteristic disingenuousness, Big Pharma with
its hundreds of billions of dollars in annual profits is actually pleading poverty in an effort to goad
the government into using taxpayer money to fund the development of new
antibiotic drugs…
…which of course the drug companies will make additional billions
of dollars in profits from.
What About Colloidal Silver?
Meanwhile,
a growing body of largely ignored clinical research demonstrates that a few cents worth of colloidal silver daily,
properly administered, will generally cure just about any superbug infection.
In
fact, study after study after study after study after study after study after study have
demonstrated that silver kills drug-resistant super-pathogens.
This
has actually been known since the 1970’s, when Dr. Robert O. Becker, M.D. of
Syracuse Medical University began his pioneering research into the
infection-fighting qualities of electrically generated silver ions. At that time, he wrote:
"All of the organisms that we
tested were sensitive to the electrically generated silver ion,
including some that were resistant to all known antibiotics…In no case
were any undesirable side effects of the silver treatment apparent."
-- Dr. Robert
O. Becker, M.D., Syracuse Medical University
And
the simple fact that silver kills antibiotic-resistant microbes has been
re-confirmed time after time. As
recently stated in a 2010 clinical study published in the World Journal of Microbiology and Biotechnology:
"Infections caused by
drug-resistant microorganisms result in significant increases in mortality,
morbidity, and cost related to prolonged treatments.
The antibacterial activity of
silver nanoparticles against some drug-resistant bacteria has been established…
Hence, we challenged different
drug-resistant pathogens of clinical importance (multidrug-resistant
Pseudomonas aeruginosa, ampicillin-resistant
Escherichia coli O157:H7 and erythromycin-resistant Streptococcus pyogenes) with a suspension of silver nanoparticles.
By means of a luciferase-based
assay, it was determined that silver nanoparticles:
(1) inactivate
a panel of drug-resistant and drug-susceptible bacteria (Gram positive and Gram
negative),
(2) exert
their antibacterial activity through a bactericidal rather than bacteriostatic mechanism, and
(3) inhibit
the bacterial growth rate from the time of first contact between the bacteria
and the nanoparticles."
-- World J Microbiol Biotechnol (2010)
26:615–621
What’s
more, studies from
BYU
have demonstrated that simply adding colloidal silver to an existing
prescription antibiotic drug that has lost its effectiveness against the
superbugs, increases the efficacy of that drug manifold, and renders it effective against the superbugs once again!
So
really, it appears there’s no need to develop new antibiotic drugs to fight the
superpathogens.
Just add a little bit of colloidal silver to the existing drugs, and
they become supercharged!
This
too has been repeatedly documented by other researchers. The most recent study was conducted by
clinical researchers at the Andalusian Center for
Molecular Biology & Regenerative Medicine and University of Seville at
Seville, Spain:
“Recently, due to the emergence of
antibiotic-resistant bacteria and the use limitations of antibiotics that can
cause serious diseases and is an important public health problem (Furuya & Lowy, 2006), the synergetic effect of
silver nanoparticles with antibiotics has been studied combinating
silver nanoparticles with different antibiotics like ampicillin, kanamycin,
erythromycin and chloramphenicol against gram
positive and gram negative bacteria.
The antibacterial activities of
these antibiotics increase in the presence of silver nanoparticles against gram
positive and gram negative bacteria determined by the disk diffusion method.
…The antibiotic molecules contain
many active groups such as hydroxyl and amino groups, which reacts easily with
silver nanoparticles by chelation,
for this reason, the synergistic effect may be caused by the bonding
reaction with antibiotic and silver nanoparticles.”
-- Silver Nanoparticles
Interactions With the Immune System: Implications for Health
and Disease, CABIMER-Andalusian Center for Molecular
Biology & Regenerative Medicine
Want
more evidence that antimicrobial silver is the clear solution to the growing
super-pathogen crisis. Here are just a
few insightful articles you might want to read:
·
Colloidal Silver Cures Pseudomonas
·
Colloidal
Silver Cures Salmonella
·
Colloidal
Silver Cures Streptococcus Pyogenes
·
Colloidal Silver Cures E. Coli
·
Colloidal Silver Curse Listeria
Meanwhile,
the drug companies continue to ignore silver-based antimicrobials as the only
viable, immediate solution to the ever-growing
crisis of super-pathogens.
And why?
Clearly,
it’s because they’re not looking for
a quick, safe and effective solution to the millions of deaths per year caused
by the super-pathogens worldwide.
Instead,
they’re pushing the governments of the world to tap deeper into the taxpayer’s
pocketbooks to pay for research and development into new classes of antibiotic
drugs.
And
of course, because the pathogens become resistant to most new drugs within a
matter of months or years, the taxpayer-funded research and development of new
drugs will be a never-ending source of
revenue for Big Pharma.
The
bottom line is that when the taxpayers have to foot the bill for the R&D,
then new antibiotic drugs will be developed.
And
these new drugs will represent billions upon billions of dollars in pure profits for Big Pharma,
because they won’t have to pay for their own research and development.
Can You See
The Handwriting On the Wall?
What
does this tell you?
Well,
if you’re intelligent, it should tell you to start stocking up on colloidal
silver, because the drug companies are about to use the same blackmail tactic
here in the U.S. they just finished using in the EU.
This
means the super-pathogen crisis is going to get a lot worse here, first. That’s the leverage the big pharmaceutical companies intend to use to force
the government to start providing taxpayer money to fund their research into
the development of new antibiotics.
So
you’ll want to have plenty of this powerful, infection-fighting elixir
available in the interim.
Of
course, colloidal silver is costly, with tiny four-ounce bottles going for as
much as $30 apiece in health food stores.
Therefore,
you might want to consider obtaining a new Micro-Particle Colloidal Silver Generator so you can
make all of the high-quality colloidal silver you could ever need for just a
few pennies per one-quart batch, any
time you need it to protect yourself and your family.
To
learn how easy it is to start making your own high-quality micro-particle
colloidal silver, just click the link above.
Or,
check out this link to learn how
thousands of experienced colloidal silver users are already curing their own
infections with high-quality, homemade micro-particle colloidal silver.
Frankly,
making your own high-quality micro-particle colloidal silver the simplest and
most effective way in the world to tell Big Pharma
where to shove it, while protecting yourself and your family from infection and
disease at the same time.
The
time has clearly come for people to take their health and well-being into their
own hands, and tell the big drug companies to pound sand.
Owning
the means of colloidal silver production is one of the most effective ways you
can do that.
And
if you’re concerned about dosage, you can get a copy by email of the FREE
Colloidal Silver Safe Dosage Report at www.ColloidalSilverSafeDosageReport.com.
Yours for the
safe, sane and responsible use of
colloidal silver,
Steve
Barwick, author
The Ultimate Colloidal Silver Manual
Helpful Links:
Join the Colloidal Silver Secrets
Community on Facebook
Video: Learn How to Make
Micro-Particle Colloidal Silver
Get Your FREE
Colloidal Silver “Safe Dosage” Report
.999 Fine
Pure Silver Wire for Making Colloidal Silver
The New Micro-Particle Colloidal
Silver Generator
Subscribe to the
Colloidal Silver Secrets Ezine
Make Your Own Colloidal Silver
Inexpensively
Real-Life Colloidal
Silver Success Stories
Colloidal Silver Update (News &
Views)
The Ultimate Colloidal
Silver Manual
The Colloidal
Silver Secrets Video
Colloidal Silver
Kills Viruses
Important Note and
Disclaimer: The contents of this Ezine have not been
evaluated by the Food and Drug Administration.
Information conveyed herein is from sources deemed to be accurate and
reliable, but no guarantee can be made in regards to the accuracy and
reliability thereof. The author, Steve
Barwick, is a natural health journalist with over 30 years of experience
writing professionally about natural health topics. He is not
a doctor. Therefore, nothing stated in
this Ezine should be construed as prescriptive in nature, nor is any part of
this Ezine meant to be considered a substitute for professional medical
advice. Nothing reported herein is
intended to diagnose, treat, cure or prevent any disease. The author is simply reporting in
journalistic fashion what he has learned during the past 17 years of
journalistic research into colloidal silver and its usage. Therefore, the information and data presented
should be considered for informational purposes only, and approached with
caution. Readers should verify for
themselves, and to their own satisfaction, from other knowledgeable sources
such as their doctor, the accuracy and reliability of all reports, ideas,
conclusions, comments and opinions stated herein. All important health care decisions should be
made under the guidance and direction of a legitimate, knowledgeable and
experienced health care professional.
Readers are solely responsible for their choices. The author and publisher disclaim responsibility
or liability for any loss or hardship that may be incurred as a result of the
use or application of any information included in this Ezine.
